at Zacks.com (Wed, 1:20PM)
UBS takes a shine to a pair of tobacco names, raising its price target on buy-rated Altria (MO +0.1%) and Lorillard (LO -0.7%). Despite a strong run that has seen the duo outperform consumer staples by a healthy margin in 2012, analyst Nik Modu says strong sector rotation, low interest rates, and favorable pricing remains in play.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Nasdaq.com (Jan 20, 2015)
at Benzinga.com (Jan 15, 2015)
at Benzinga.com (Jan 14, 2015)
at CNBC.com (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs